David Colman1, Catherine Lubetzki, Stephen Reingold
1Montreal Neurological Institute, 3801 University Avenue, Montreal, PQ, Canada H3A 2B4.
Multiple sclerosis (MS) is a central nervous system (CNS) inflammatory disease affecting about 1 in 1000 people. Current treatments reduce inflammation, while new strategies aim to repair CNS damage, offering hope for functional recovery.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: